Cytotoxic activity of epidermal growth factor-genistein against breast cancer cells.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Clinical Cancer Research

• Publication date

  1998-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9563884
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EGF receptor expression, regulation, and function in breast cancer

  2004cited by this paper
• The epidermal growth factor receptor as a target for therapy in breast carcinoma

  2004cited by this paper
• Construction and functional characterization of scFv(14E1)-ETA - a novel, highly potent antibody-toxin specific for the EGF receptor.

  1997cited by this paper
• Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase.

  1997cited by this paper
• Requirement for c-Src Catalytic Activity and the SH3 Domain in Platelet-derived Growth Factor BB and Epidermal Growth Factor Mitogenic Signaling*

  1996cited by this paper
• BTK as a Mediator of Radiation-Induced Apoptosis in DT-40 Lymphoma B Cells

  1996cited by this paper
• Membrane-associated CD19-LYN complex is an endogenous p53-independent and Bcl-2-independent regulator of apoptosis in human B-lineage lymphoma cells

  1996cited by this paper
• An Incomplete Program of Cellular Tyrosine Phosphorylations Induced by Kinase-defective Epidermal Growth Factor Receptors (*)

  1995cited by this paper
• Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases

  1995cited by this paper
• Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research

  1995cited by this paper
• Membrane-associated CD19-LYN complex is an endogenous p53-independent and Bc1-2-independent regulator of apoptosis in human B-lineage lymphoma cells.

  1995cited by this paper
• Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes. Ten-year results.

  1995cited by this paper
• Randomized trial of cyclophosphamide, methotrexate, and 5‐fluorouracil with or without estrogenic recruitment in women with metastatic breast cancer

  1994cited by this paper
• BE‐23372M, a Novel and Specific Inhibitor for Epidermal Growth Factor Receptor Kinase

  1994cited by this paper
• High‐dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high‐risk primary breast cancer

  1994cited by this paper
• New chemotherapeutic agents for breast cancer

  1994cited by this paper
• Progress from clinical trials on breast cancer

  1994cited by this paper
• Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity

  1994cited by this paper
• A specific inhibitor of the epidermal growth factor receptor tyrosine kinase.

  1994cited by this paper
• EGF receptor in neoplasia and metastasis

  1993cited by this paper
• Signal transduction through the CD19 receptor during discrete developmental stages of human B-cell ontogeny.

  1993cited by this paper
• Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product.

  1992cited by this paper
• Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor.

  1992cited by this paper
• The EGF receptor system as a target for antitumor therapy.

  1991cited by this paper
• Epidermal growth factor receptor expression as a prognostic indicator in breast cancer.

  1991cited by this paper
• High Accuracy Molecular Weight Determination and Variation Characterization of Proteins Up To 80 ku by Ionspray Mass Spectrometry

  1991cited by this paper
• Epidermal growth factor.

  1990cited by this paper
• The epidermal growth factor receptor as a target for therapy.

  1990cited by this paper
• Tyrphostins inhibit epidermal growth factor (EGF)-receptor tyrosine kinase activity in living cells and EGF-stimulated cell proliferation.

  1989cited by this paper
• Leukemic B-cell precursors constitutively express functional receptors for human interleukin-1.

  1989cited by this paper
• Characterization of recombinant human epidermal growth factor produced in yeast.

  1988cited by this paper
• Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors

  1988cited by this paper
• The determination of protein, oligonucleotide and peptide molecular weights by ion-spray mass spectrometry.

  1988cited by this paper
• Epidermal growth factor

  1972cited by this paper

• Exposure of androgen mimicking environmental chemicals enhances proliferation of prostate cancer (LNCaP) cells by inducing AR expression and epigenetic modifications.

  2021cites this paper
• Quinoa Secondary Metabolites and Their Biological Activities or Functions

  2019cites this paper
• FGF2 Dual Warhead Conjugate with Monomethyl Auristatin E and α-Amanitin Displays a Cytotoxic Effect towards Cancer Cells Overproducing FGF Receptor 1

  2018cites this paper
• Genistein reduces the activation of AKT and EGFR, and the production of IL6 in cholangiocarcinoma cells involving estrogen and estrogen receptors.

  2018cites this paper
• Natural product chemistry and anticancer drug discovery

  2014cites this paper
• Significance of apoptosis related proteins on malignant transformation of ovarian tumors: A comparison between Bcl-2/Bax ratio and p53 immunoreactivity.

  2014cites this paper
• Kinase inhibitor conjugates.

  2012cites this paper
• Epidermal Growth Factor Receptor Signaling in Nonsmall Cell Lung Cancer

  2010cites this paper
• Bevacizumab/docetaxel association is more efficient than docetaxel alone in reducing breast and prostate cancer cell growth: a new paradigm for understanding the therapeutic effect of combined treatment.

  2010cites this paper
• Targeting the EGF Receptor for Ovarian Cancer Therapy

  2009cites this paper
• Targeting the tumor microenvironment (Stroma) for treatment of metastasis

  2008cites this paper
• IGF-I- and EGF-dependent DNA synthesis of porcine myoblasts is influenced by the dietary isoflavones genistein and daidzein.

  2008cites this paper
• Significance of tyrosine kinase activity on malign transformation of ovarian tumors: a comparison between EGF-R and TGF-alpha.

  2008cites this paper
• Flavonoids as RTK inhibitors and potential anticancer agents

  2008cites this paper
• Synthesis and evaluation of the antiproliferative activities of derivatives of carboxyalkyl isoflavones linked to N-t-Boc-hexylenediamine.

  2007cites this paper
• Influence of topoisomerase II inhibitors and ionizing radiation on growth arrest and cell death pathways in the breast tumor cell

  2007cites this paper
• Extended treatment with physiological concentrations of dietary phytochemicals results in altered gene expression , reduced growth and apoptosis of cancer cells

  2007cites this paper
• Effect of Targeting Janus Kinase 3 on the Development of Intestinal Tumors in the Adenomatous Polyposis Colimin Mouse Model of Familial Adenomatous Polyposis

  2007cites this paper
• Phytoestrogens: perpetrators or protectors?

  2007cites this paper
• Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells

  2007influential citation
• Cytotoxicity of a recombinant fusion protein of adenovirus early region 4 open reading frame 4 (E4orf4) and human epidermal growth factor on p53-deficient tumor cells

  2006cites this paper
• Structural influence on the intermolecular/intramolecular hydrogen bonding in solid state of substituted leflunomides : evidence by X-ray crystal structure

  2005cites this paper
• Sensitive and specific quantification of the anticancer agent ZD1839 (Gefitinib) in plasma by on-column focusing capillary liquid chromatography-tandem mass spectrometry.

  2005cites this paper
• hydroxylphenyl )-amino-6 , 7-dimethoxyquinazoline : A Novel Quinazoline Derivative with Potent Cytotoxic Activity against Human Glioblastoma Cells

  2005cites this paper
• Caiphostin C Triggers Calcium-dependent Apoptosis in Human Acute Lymphoblastic Leukemia Cells1

  2005cites this paper
• Protein phosphatase inhibition: structure based design. Towards new therapeutic agents.

  2004cites this paper
• A highly effective and stable bispecific diabody for cancer immunotherapy: cure of xenografted tumors by bispecific diabody and T-LAK cells

  2004cites this paper
• Human Stomach Cancer Cells Undergo Apoptosis by Genistein, But Not Other Genistein-and Daidzein-Related Compounds

  2004cites this paper
• Anticancer therapeutic potential of soy isoflavone, genistein.

  2004cites this paper
• Tyrosine Kinase Inhibitors in Preclinical Development

  2004cites this paper
• Synthesis of a Piceatannol Analog: Replacement of Hydroxy Group with Amide Functionality

  2004cites this paper
• Epidermal growth factor receptor as a target to improve treatment of lung cancer.

  2004cites this paper
• Simultaneous Blockade of Platelet-Derived Growth Factor-Receptor and Epidermal Growth Factor-Receptor Signaling and Systemic Administration of Paclitaxel as Therapy for Human Prostate Cancer Metastasis in Bone of Nude Mice

  2004cites this paper
• Supramolecular structures of 2-cyano-3-dimethylamino-N-(4-methylphenyl)acrylamide and 2-cyano-3-dimethylamino-N-(2-methoxyphenyl)acrylamide.

  2003cites this paper
• Targeting colon cancer cells with genistein-17.1A immunoconjugate.

  2003cites this paper
• Novel antiviral agent tetraglycylated nordihydroguaiaretic acid hydrochloride as a host-dependent viral inhibitor.

  2003cites this paper
• Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growing in the bone of nude mice.

  2003cites this paper
• Phytoestrogens and breast cancer.

  2002cites this paper
• Selective inhibition of the epidermal growth factor receptor by ZD1839 decreases the growth and invasion of ovarian clear cell adenocarcinoma cells.

  2002cites this paper
• A sensitive assay for ZD1839 (Iressa) in human plasma by liquid-liquid extraction and high performance liquid chromatography with mass spectrometric detection: validation and use in Phase I clinical trials.

  2002cites this paper
• Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer.

  2002cites this paper
• Monoclonal antibodies to target epidermal growth factor receptor–positive tumors

  2002cites this paper
• Blockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomas.

  2002cites this paper
• Isolation of two highly potent and non-toxic inhibitors of human immunodeficiency virus type 1 (HIV-1) integrase from Salvia miltiorrhiza.

  2002cites this paper
• Induction of Apoptosis by Genistein: Potential Applications in Cancer Prevention and Treatment

  2002cites this paper
• Industrial Processing and Preparation of Isoflavones

  2002cites this paper
• Expression of Growth Factors, Growth Factor Receptors and Apoptosis Related Proteins in Invasive Breast Cancer: Relation to Apoptotic Rate

  2001cites this paper
• Pharmacokinetics and Tolerability of the Orally Active Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 in Healthy Volunteers

  2001cites this paper
• Structure-based design of novel anticancer agents.

  2001cites this paper
• Rationally designed anti-mitotic agents with pro-apoptotic activity.

  2001cites this paper
• High-performance liquid chromatographic methods for the determination of topoisomerase II inhibitors.

  2001cites this paper
• Optimization for the blockade of epidermal growth factor receptor signaling for therapy of human pancreatic carcinoma.

  2001cites this paper
• Novel antineoplastic isochalcones inhibit the expression of cyclooxygenase 1,2 and EGF in human prostate cancer cell line LNCaP.

  2001cites this paper
• Apoptosis Inducing Novel Anti-Leukemic Agent, Bis(4,7-Dimethyl-1,10 Phenanthroline) Sulfatooxovanadium(IV)[VO(SO4)(Me2-Phen)2] Depolarizes Mitochondrial Membranes

  2001cites this paper
• ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR‐positive cancer cell lines with or without erbB2 overexpression

  2001cites this paper
• The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design?

  2001cites this paper
• Rational design of potent and selective EGFR tyrosine kinase inhibitors as anticancer agents.

  2001cites this paper
• The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification.

  2001cites this paper
• Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma.

  2000cites this paper
• Growth arrest and cell death in the breast tumor cell in response to ionizing radiation and chemotherapeutic agents which induce DNA damage

  2000cites this paper
• Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily: role as anticancer agents.

  2000cites this paper
• Apolipoprotein E and apolipoprotein D expression in a murine model of singlet oxygen-induced cerebral stroke.

  2000cites this paper
• Human Breast Carcinoma Cells Express Type II IL-4 Receptors and Are Sensitive to Antitumor Activity of a Chimeric IL-4-Pseudomonas Exotoxin Fusion Protein in vitro and in vivo

  2000influential citation
• EGF-genistein inhibits neointimal hyperplasia after vascular injury in an experimental restenosis model.

  2000cites this paper
• Genistein induces apoptosis and topoisomerase II-mediated DNA breakage in colon cancer cells.

  2000cites this paper
• Liposome targeting to tumors using vitamin and growth factor receptors.

  2000cites this paper
• Genistein: does it prevent or promote breast cancer?

  2000cites this paper
• Tyrosine Kinase Inhibitors Targeted to the Epidermal Growth Factor Receptor Subfamily

  2000cites this paper
• Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent.

  2000cites this paper
• The Raf signal transduction cascade as a target for chemotherapeutic intervention in growth factor-responsive tumors.

  2000cites this paper
• Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents.

  1999cites this paper
• Five analogs of the active metabolite of leflunomide

  1999cites this paper
• Targeting Janus Kinase 3 in Mast Cells Prevents Immediate Hypersensitivity Reactions and Anaphylaxis*

  1999cites this paper
• Genetic and biochemical evidence for a critical role of Janus kinase (JAK)-3 in mast cell-mediated type I hypersensitivity reactions.

  1999cites this paper
• Increased hydroxyl radical production and apoptosis in PC12 neuron cells expressing the gain-of-function mutant G93A SOD1 gene.

  1999cites this paper
• Synthesis, characterization and preclinical formulation of a dual-action phenyl phosphate derivative of bromo-methoxy zidovudine (compound WHI-07) with potent anti-HIV and spermicidal activities.

  1999cites this paper
• Bruton’s Tyrosine Kinase as an Inhibitor of the Fas/CD95 Death-inducing Signaling Complex*

  1999cites this paper
• Growth Factors, Apoptosis, and Survival of Mammary Epithelial Cells

  1999cites this paper
• Specificity of α-Cyano-β-Hydroxy-β-Methyl-N-[4-(Trifluoromethoxy)Phenyl]-Propenamide as an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase

  1999cites this paper
• Structure-based design of potent inhibitors of EGF-receptor tyrosine kinase as anti-cancer agents.

  1999cites this paper
• The epidermal growth factor receptor and its inhibition in cancer therapy.

  1999cites this paper
• Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia.

  1999cites this paper
• Specificity of alpha-cyano-beta-hydroxy-beta-methyl-n-[4-(trifluoromethoxy)phe nyl]-propenamide as an inhibitor of the epidermal growth factor receptor tyrosine kinase.

  1999cites this paper
• Alpha-cyano-beta-hydroxy-beta-methyl-N-[4-(trifluoromethoxy)phenyl] propenamide: an inhibitor of the epidermal growth factor receptor tyrosine kinase with potent cytotoxic activity against breast cancer cells.

  1998cites this paper
• Calphostin C triggers calcium-dependent apoptosis in human acute lymphoblastic leukemia cells.

  1998cites this paper
• In vivo toxicity, pharmacokinetics, and anticancer activity of Genistein linked to recombinant human epidermal growth factor.

  1998cites this paper
• Soyfoods, isoflavones and risk of colonic cancer: a review of the in vitro and in vivo data.

  1998cites this paper
• 4-(3'-Bromo-4'hydroxylphenyl)-amino-6,7-dimethoxyquinazoline: a novel quinazoline derivative with potent cytotoxic activity against human glioblastoma cells.

  1998cites this paper